Health

REPEAT – Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an…

5 months ago

Hapbee Expands Community Monetization with Gift-A-Friend and Referral Programs

Designed by Hapbee's Chief Innovation Officer and NBA Finals MVP Jaylen Brown to build upon the concept of giving, the…

5 months ago

Nova Leap Health Corp. Posts Record Q2 2025 Results

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 07, 2025…

5 months ago

Coherus Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update

– LOQTORZI net revenue was $10.0 million, a 36% increase over Q1 2025 – – Data readouts for CHS-114 and…

5 months ago

Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy

August 07, 2025 16:30 ET  | Source: Annexon Biosciences New Pilot Appoints Designated Product Development Coordinator to Navigate Regulatory Interactions,…

5 months ago

Extendicare Announces 2025 Second Quarter Results

MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for…

5 months ago

Cannabis: The Gateway to Tomatoes? New Survey Says Yes

FORT LAUDERDALE, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cannabis isn’t just transforming laws and lifestyles but also transforming America’s…

5 months ago

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 06, 2025 16:45 ET  | Source: Neuronetics MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),…

5 months ago

BriaCell Announces Proposed Effective Date of Share Consolidation

August 05, 2025 20:17 ET  | Source: BriaCell Therapeutics Corp. PHILADELPHIA and VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE)…

5 months ago

Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management

Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin…

5 months ago